Boeing CEO says company still needs ‘a couple more years’ to repair finances before new jet
CEO Kelly Ortberg signalled Boeing is focused more on stabilizing its existing business than rushing to develop a successor to its bestselling 737 MAX.
China’s car market heads for worst year since 2021 as sales plunge 20%
Consumer demand for cars in China tumbles following record-high sales of 23.7 million units in 2025.
Ryanair says ‘no shortage’ of travelers despite Iran war denting profit
Ryanair’s first-quarter profit took a 34% hit as consumers delayed bookings due to the Middle East crisis, while struggling airlines face a “difficult winter.”
CNBC Daily Open: Burnham set to take helm of ‘poverty stricken disaster,’ says Trump
Britain’s new Prime Minister Andy Burnham faces instant pressure from President Trump to “open up” North Sea oil.
From ‘Super El Niño’ to Europe’s extreme heatwave: How this year’s weather shocks are rattling commodity markets
Markets are underestimating the impact of climate volatility on a range of asset classes, commodity strategists say.
FIFA emerges as the $9 billion winner as the biggest, brashest World Cup ever draws to a close
The football governing body presided over the most lucrative sporting event in history and is poised to net over $9 billion in revenue for 2026.
Russia pounds Kyiv as NATO military chief warns Moscow would ‘lose a lot’ by attacking Baltics
Russia and Ukraine traded their heaviest strikes in months, fueling fears of escalation and further strain on oil supplies.
‘Give me my money back’: South Korean traders’ leveraged SK Hynix, Samsung bets unravel after sell-off
South Korean retail investors suffer heavy losses after Samsung and SK Hynix shares reverse sharply.
China’s Zhongji Innolight sees shares surge after Hong Kong listing approval
The deal size will exceed Luxshare Precision’s $3.1 billion IPO earlier this month, making it the largest listing in Hong Kong this year.
Samsung Biologics to acquire Switzerland’s PolyPeptide Group in $1.8 billion all-cash deal
South Korea’s Samsung Biologics said on Monday that it had made an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland’s PolyPeptide Group.
